By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Nutra Pharma Corp. 

3473 High Ridge Road

Boynton Beach  Florida  33426  U.S.A.
Phone: 954-509-0911 Fax: 877-895-5647


Nutra Pharma Corporation is a biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases. Nutra Pharma Corp. through its subsidiaries carries out basic drug discovery research and clinical development and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process. Nutra Pharma continues to identify and acquire intellectual property and companies in the biotechnology arena. By bringing a solid business foundation to the Company's Biotech holdings, Nutra Pharma has the ability to accelerate business plans, streamline costs and bring products to the market or licensure in a time-effective manner.

Nutra Pharma currently has three holdings:

  • The minority-owned subsidiary, ReceptoPharm, Inc, is developing technologies for the development of drugs for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis ("MS").

  • The minority-owned holding, Infectech, Inc., is engaged in the research and development of diagnostic test kits designed to be used for the rapid identification of infectious diseases such as Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI).

  • Lastly, the wholly-owned subsidiary Portage BioMed is developing novel and proprietary drug delivery systems to be used with various drug therapies in the treatment of diseases. Their primary research is in creating innovative systems for the safer and more efficient distribution of existing chemotherapeutic agents in the treatment of cancer.

    Key Management:
    Rik J Deitsch, Chairman of the Board; President and Chief Executive Officer
    Stanley J Cherelstein, Director; Principal Accounting Officer
    Stewart Lonky, MD, Director; Science Chairman
    Tanivir Khandaker, MD, Director; Partnerships and Acquisition Chairman
    Michael Doherty, Chairman of the Board

    Last Updated: 11-28-05

    Key Statistics

    Ownership: Public

    Web Site: Nutra Pharma Corp.
    Employees: 10
    Symbol: NPHC

  • Industry

    Company News
    Nutra Pharma Corp. (NPHC) Announcing Launch Of Luxury Feet 6/23/2017 8:14:46 AM
    Nutra Pharma Corp. (NPHC) Featured On Univision's Spanish-Language News Show: Primer Impacto 6/8/2017 7:59:41 AM
    Nutra Pharma Corp. (NPHC) Announces Collaboration With The University of Maryland Bioprocess Scale-Up Facility In Preparation Of Material For Phase II Studies 6/2/2017 6:37:27 AM
    Nutra Pharma Corp. (NPHC) Announces Collaboration With The International Security Group For Development Of Nerve Agent Counter Measures 5/26/2017 6:59:57 AM
    Nutra Pharma Corp. (NPHC) CEO Rik Deitsch Interviewed By 3/15/2017 12:06:26 PM
    Global Small Caps Initiates Coverage On Nutra Pharma Corp. (NPHC) 2/23/2017 12:29:19 PM
    Nutra Pharma Corp. (NPHC) And Nyloxin Featured On NBC News-Miami 2/15/2017 10:37:31 AM
    Nutra Pharma Corp. (NPHC) Letter To Shareholders 12/27/2016 10:46:03 AM
    Nutra Pharma Corp. (NPHC) Announces Infomercial Campaign For Pet Pain-Away 11/16/2016 12:38:36 PM
    Nutra Pharma Corp. (NPHC) Announces Licensing And Marketing Agreement For Pet Pain-Away 11/11/2016 2:44:35 PM